Caspase-2 belongs to the caspase family of cysteine proteases with established roles in apoptosis. Recently, caspase-2 has been implicated in nonapoptotic functions including maintenance of genomic stability and tumor suppression. Our previous studies demonstrated that caspase-2 also regulates cellular redox status and delays the onset of several ageing-related traits. In the current study, we tested stress tolerance ability in caspase-2-deficient (Casp2 −/− ) mice by challenging both young and old mice with a low dose of the potent reactive oxygen species (ROS) generator, PQ that primarily affects lungs. In both groups of mice, PQ induced pulmonary damage. However, the lesions in caspase-2 knockout mice were consistently and reproducibly more severe than those in wild-type (WT) mice. Furthermore, serum interleukin (IL)-1β and IL-6 levels were higher in PQ-exposed aged Casp2 −/− mice indicating increased inflammation. Interestingly, livers from Casp2 −/− mice displayed karyomegaly, a feature commonly associated with ageing and aneuploidy. Given that Casp2 −/− mice show impaired antioxidant defense, we tested oxidative damage in these mice. Protein oxidation significantly increased in PQ-injected old Casp2 −/− mice. Moreover, FoxO1, SOD2 and Nrf2 expression levels were reduced and induction of superoxide dismutase (SOD) and glutathione peroxidase activity was not observed in PQ-treated Casp2 −/− mice. Strong c-Jun amino-terminal kinase (JNK) activation was observed in Casp2 −/− mice, indicative of increased stress. Together, our data strongly suggest that caspase-2 deficiency leads to increased cellular stress largely because these mice fail to respond to oxidative stress by upregulating their antioxidant defense mechanism. This makes the mice more vulnerable to exogenous challenges and may partly explain the shorter lifespan of Casp2 −/− mice.
INTRODUCTION
Caspase-2, the most conserved member of the caspase family, 1 has an established role in apoptosis. [2] [3] [4] [5] Recent studies implicate caspase-2 in several non-apoptotic functions. 6 Caspase-2 acts as a tumor suppressor in some mouse models of cancer [6] [7] [8] but not in a MYCN neuroblastoma model, 9 and is responsible for the maintenance of genomic stability, 6, 8, 10 and prevents early ageing. 11, 12 We have previously demonstrated that caspase-2-deficient mice exhibit increased oxidative stress with age and reduced tolerance to alcohol-induced cellular stress due to the inability to regulate the antioxidant response.
11
Paraquat (PQ) is a broad-spectrum herbicide, which undergoes a cyclic oxidation-reduction reaction to produce superoxide radical (O 2 − ). 13, 14 Following ingestion or inhalation, this herbicide selectively accumulates in the lung and PQ metabolites are produced by Clara cells. These metabolites promote local release of free radicals in the lung, which cause extensive injury to Clara cells and to the blood-air barrier, presumably through lipid peroxidation of type I and II pneumocytes and alveolar microvascular endothelial cells. 13, 15 PQ toxicity has been widely used as a model of oxidant-induced alveolar injury and pulmonary fibrosis. High doses of PQ are more likely to cause fulminating pulmonary edema and hemorrhage, whereas lower doses allow time for tissue repair and induces hyperplasia of alveolar type II pneumocytes and fibrosis. 16 It has long been realized that ability to withstand stress is linked to longevity. 17, 18 Our previous studies show that Casp2 −/− mice age early and have a shorter lifespan due, at least in part, to increased oxidative stress and impaired antioxidant system. 11 The present study was carried out to investigate this further, using PQ to challenge mice with reactive oxygen species (ROS). N-acetyl cysteine (NAC) was used as an antioxidant to rescue PQ-induced damage.
Our data demonstrate that caspase-2 is activated upon PQ-induced stress. Wild-type (WT) mice respond to the oxidative challenge that is indicated by increased activity of antioxidant enzymes. This robust stress response prevents excessive cellular damage. On the contrary, PQ caused extensive damage in Casp2 −/− mice, which was associated with poor stress response. We conclude that the inability of Casp2 −/− mice to respond to oxidative challenge makes them more susceptible to further damage that may be responsible for the early-ageing phenotype observed in these mice.
RESULTS AND DISCUSSION
Caspase-2 deficiency increases PQ-induced lung damage Casp2 −/− mice have a reduced maximum lifespan, display several early-ageing phenotypes and experience oxidative stress. 11, 12 We challenged both young (3-4 month) and aged (12-15 month) mice with PQ to check their ability to handle exogenous stressors. Initially, a pilot study was performed using young mice with increasing PQ concentration (all below the LD 50 dose (dose lethal to 50% of animals tested)). 15, 19 WT and Casp2 −/− mice were given a single PQ injection and observed for 2 weeks after which they were humanely killed. All mice survived during the 2-week observation period. Whereas there was a dose-dependent decline in body weight, there were no significant differences observed between WT and Casp2 −/− mice (Supplementary Figure S1A) . Fluid retention (wet/dry weight) in mice lungs increased even at the lowest tested PQ dose and was associated with increased protein oxidation ( Supplementary Figures S1B and C) . Interestingly, we observed significantly increased lipid peroxidation only in Casp2 −/− mice at the highest PQ dose (Supplementary Figure S1D ). Lungs and livers from the treated mice were stained with hematoxylin and eosin. In both groups of mice, PQ produced the two hallmark lesions of pulmonary damage resulting from exposure to this herbicide: 20 (i) necrosis of the microvascular endothelium, with resulting edema and hemorrhage and (ii) epithelial necrosis (type I pneumocytes) in alveolar walls (Supplementary Figure S2A) . There was also evidence of hyperplasia of type II pneumocytes, which was significant at 20 and 30 mg/kg dose. However, pulmonary lesions in Casp2 −/− mice were more extensive than those seen in WT mice receiving the same PQ dose (Supplementary Figure S2A) . Remarkably, we observed that, while PQ-induced hepatocyte karyomegaly in a dose-dependent manner in both aged WT and Casp2 −/− mice, the nucleus:cytoplasmic ratios were significantly higher in aged Casp2 −/− mice (Supplementary Figures S2B and C). Following these observations, we used a dose of 15-mg/kg PQ with or without NAC supplementation, for further studies. The lung wet/dry ratio increased significantly in both young and aged PQ-injected Casp2 −/− mice compared with control mice injected with phosphate buffered saline (PBS) (Figures 1c-f Examination of lungs by histology was carried out in both old (Figure 2a and Supplementary Figure S3 ) and young (Supplementary Figure S4A) mice. In the lungs of WT mice, alveolar walls were either largely unaffected or the alveolar interstitium was mildly thickened by congestion, edema and minor erythrocyte extravasation, with an occasional type II pneumocyte (arrows) or foamy macrophage (arrowhead) present (Figure 2a and Supplementary Figure S3A ). By contrast, alveolar walls in Casp2 −/− mice were generally greatly thickened by eosinophilic protein-rich edema fluid, hemorrhage and contained prominent type II pneumocyte proliferation (Supplementary Figure S3B ) with a few infiltrating lymphocytes (Figure 2a and Supplementary Figure S3B) . In old Casp2 −/− mice lungs, there was also frequently perivascular lymphoplasmacytic cuffing, which was sometimes marked (Supplementary Figure S3C) . PQ injection along with NAC provided partial rescue as patchy areas with thickened alveolar walls were often observed in young (Supplementary Figure S4A) and old mice (Figure 2a ) from both genotypes.
In the normal mouse liver, there are some variabilities in hepatocyte nuclear size. Consistent with our earlier observation, low dose (15 mg/kg) PQ treatment caused hepatocyte karyomegaly in both WT and Casp2 −/− mice. However, in Casp2 −/− mice given PQ, hepatocytes with enlarged nuclei were frequently observed and nuclear:cytoplasmic ratio was consistently greater than in WT mouse livers after detailed morphometric analysis. This was observed in both young and old Casp2 / MMTV animals were found to display abnormal karyomegaly with frequent presence of multinucleation and abnormal mitoses, whereas Casp2 +/+ /MMTV mice did not show these defects. 21 Moreover, these tumor cells displayed high proliferation rate further reinforcing the fact that cell cycle defects commonly occur in Casp2 −/− cells when subjected to a sensitized background. The adult mammalian liver frequently has anueploid cells. 22 It is well known that hepatocytes change ploidy normally during development and in response to chemical challenges, such as toxins as well as with advanced age. [23] [24] [25] Excessive ROS generated by PQ affects the cell cycle machinery. Ploidy changes occur when severely damaged cells adapt to the situation by inducing cell cycle arrest and repair. Given that loss of caspase-2 results in higher ROS levels, the appearance of enlarged nuclei in knockout mice at a lower PQ dose as well as increased karyomegaly in Casp2 −/− compared with WT mice subjected to same PQ dose suggests a low threshold to withstand ROS challenge and clearly represents a situation where Casp2 −/− mice show reduced stress tolerance.
Aged Casp2
−/− mice have increased interleukin (IL)-6 and IL-1β after PQ exposure PQ accumulates in the lungs causing pulmonary edema, alveolar destruction and ultimately pulmonary fibrosis. Cytokines and growth factors act as pro-inflammatory and pro-fibrogenic factors that are responsible for disease progression. 26 As PQ injection caused accumulation of infiltrating cells in the damaged lungs, we also checked cytokine levels using mouse ELISA kits in old mice serum. IL-6 levels were significantly higher in aged PQ injected Casp2 −/− mice ( Figure 3a) . Interestingly, PBS-treated old Casp2 −/− mice also exhibited increased IL-6 compared with WT mice. This was not observed in the younger age group (data not shown). IL-1β levels did not change when comparing PBS control to PQ-treated mice of both genotypes. However, IL-1β levels were significantly elevated in the PQ-treated Casp2 −/− mice compared with PQ-treated WT mice, suggesting again that Casp2 −/− mice experience increased PQ-induced damage at such a low PQ dose ( Figure 3b ). Among other cytokines tested, tumor necrosis factor alpha (TNFα) levels were below the level of detection, whereas there was no difference in MIP2 and nitrite levels ( Figure 3c and data not shown). Higher IL-6 and IL-1β levels indicate increased inflammation and reflect the presence of advanced-stage pulmonary lesions in Casp2 −/− mice.
PQ increases oxidative stress in Casp2 −/− mice PQ-induced oxidative stress was further analysed in old mouse lungs. Protein carbonyls increased with PQ exposure and levels were significantly higher in Casp2 −/− mice. This suggests more protein oxidation in Casp2 −/− mice. NAC pre-treatment reduced protein oxidation, but the levels were still substantially higher in Casp2 −/− mice, suggesting that NAC does not completely rescue the damage caused by PQ (Figure 3d) .
PQ is known to cause extensive lipid peroxidation and both WT and Casp2 −/− mice displayed an increase in lipid peroxidation in lungs following PQ treatment. Whereas no difference was observed between PQ-treated WT and Casp2 −/− mice, the PBSinjected Casp2 −/− mice had increased amounts of lipid peroxides compared with WT control mice (Figure 3e ), suggesting that aged Casp2 −/− mice were already stressed. Superoxide dismutase (SOD) is the enzyme responsible for converting the highly reactive superoxide radicals to hydrogen peroxide that gets converted to nontoxic forms by catalase and glutathione peroxidase. We observed that both SOD activity (Figure 3f ) and glutathione peroxidase activity ( Figure 3g ) were high in PQ-treated WT mice compared with PQ-treated Casp2 −/− mice. This is consistent with our past findings demonstrating reduced antioxidant activity in Casp2 −/− aged mice, and further indicates that the increased Caspase-2 in oxidative stress S Shalini et al oxidative damage in Casp2 −/− mice occurs as a result of an underperforming antioxidant defense system. PQ causes caspase-2 activation and regulates redox status Caspase-2 is activated by PQ-induced oxidative stress. Lung tissue from WT mice treated with PQ showed cleavage of caspase-2 proenzyme, an indicator of enzyme maturation and activation. This was significantly reduced in mice supplemented with NAC in drinking water (Figure 4a ). Interestingly, we did not observe cleavage of caspase-3 ( Figure 4b ) in PQ-treated lung tissue indicating the observed cleavage of caspase-2 and the role of caspase-2 in PQ-induced oxidative stress is independent of its role in apoptosis.
In order to determine whether loss of caspase-2 then differentially affects stress signaling, we assessed p53, Nrf2, FoxO and MAPK (Erk/JNK/p38) signaling pathways in lungs. As expected, p53 expression increased after PQ administration in both WT and Casp2 −/− mice but was not different between the groups (Figure 4c and Supplementary Figure S6) . Interestingly, we observed reduced Nrf2 expression in PQ-injected Casp2 −/− mice (Figure 4c and Supplementary Figure S6) , and NAC treatment was unable to prevent reduction in total Nrf2 protein. Under basal conditions, Casp2 −/− mice had higher Nrf2 expression compared with WT mice. Given that Nrf2 is a master regulator of the antioxidant defense system 27 our data further suggest that these mice are already experiencing stress. Nrf2 is normally stabilized following stress due to oxidation and loss of its negative regulator Keap1. 28 However, when overburdened with ROS by PQ exposure, we observed lower Nrf2 expression compared with WT mice. Recently, the stability of Nrf2 under oxidative stress has been linked to reduced HDAC2 activity, which acetylates Nrf2 making it unstable. 29 Caspase-2 along with caspase-3 cleave another HDAC protein, HDAC4, promoting cytoplasmic-nuclear shuttling and apoptosis. 30 It is likely that caspase-2 exerts an indirect effect on Nrf2 activity by modulating its activity through unidentified substrates. Nrf2 is also regulated in a number of ways independent of Keap1. This includes post-translational modifications such as phosphorylation (MAPKs), ubiquitination (GSK3β) and acetylation (p300/CBP). In addition, other proteins such as p21, caveolin-1, can bind to Nrf2 and alter its stability. Post-transcriptional regulation of Nrf2 through microRNAs has also been reported. 31 Interestingly, both Nrf2 and caspase-2 have been identified as miR-34a substrates. 32, 33 Nrf2 regulates several detoxifying enzymes; therefore, its reduction in Casp2 −/− mice likely contributes to the impaired antioxidant response observed.
Furthermore, in PQ-treated mice, SOD1 expression remained unchanged across the groups. In WT mice, SOD2 expression increased after PQ treatment, whereas no change in SOD2 expression was observed in Casp2 −/− mice exposed to PQ (Figure 4d and Supplementary Figure S6) . Reduced SOD2 expression correlates with the reduced SOD activity observed earlier and again indicates that Casp2 −/− mice fail to respond to NAC-supplemented water was replaced thrice weekly. Control mice were injected with phosphate-buffered saline (PBS). Mice were checked daily for signs of respiratory distress and weight loss for a period of 2 weeks after PQ injection and then humanly killed. No change in body weight (a, d) and liver weight (b, e) were observed. Immediately after killing, lungs were removed and the left lung was weighed (wet weight). Following incubation at 85°C overnight, the lung was weighed again (dry weight). Casp2 −/− mice showed increased lung wet/dry weight ratio after PQ exposure in both young (c) and aged (f) groups. The Graph Pad Prism software, version 6 (Graph Pad Inc., La Jolla, CA, USA) was used for all statistical analyses. Data were analysed using unpaired Student's t-test. Data are presented as mean ± s.e.m. For young mice (n = 3, 3 PBS-injected; n = 5,6 PQ-injected and n = 5,5 PQ+ NAC-injected) and aged mice (n = 5,5 PBS injected; n = 9,9 PQ injected and n = 9,9 PQ+ NAC injected). *Po0.05, **Po0.01 and ***Po0.001 denote significant differences. Casp2 −/− mice 48 have been described previously and have been backcrossed to a C57BL/6 background for at least 20 generations. All animals were maintained in pathogen-free conditions and the protocols were approved by the SA Pathology/Central Northern Adelaide Health Services Animal Ethics Committee. n = WT, Casp2 −/− mice respectively. Figure 2 . Aged Casp2 −/− mice show increased alveolar damage and hepatocyte karyomegaly after PQ exposure. Formalin-fixed lung and liver specimens were embedded in paraffin, sectioned (7 μm) and stained with hematoxylin and eosin (H/E). Representative images from (a) lungs (×40) showing prominent type II pnuemocyte (arrows) and presence of edema fluid in Casp2 −/− mice and (b) liver (×40) are shown. Scale bar represents 100 μm. (c) Area of the nucleus and cytoplasm in hepatocytes was measured using Image J and data expressed as ratio of nucleus/ cytoplasm. For each mouse, measurements were made in three hepatocytes in each field and four different fields were counted per mouse. The Graph Pad Prism software, version 6 (Graph Pad Inc.) was used for all statistical analyses. Data were analysed using unpaired Student's t-test. Data are presented as mean ± s.e.m. (n = 5,5 PBS injected; n = 8,8 PQ injected and n = 8,8 PQ+ NAC injected). *Po 0.05, **P o0.01 and ***P o0.001 denote significant differences. n = WT, Casp2 −/− mice respectively.
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Caspase-2 in oxidative stress S Shalini et al exogenous stressors. Redox-sensitive transcription factor FoxO regulates SOD2 expression. 34 PQ-injected WT mice showed an increase in FoxO1 expression; however, FoxO1 expression remained largely unchanged in Casp2 −/− mice (Figure 4d and Supplementary Figure S6) . FoxO protein levels are regulated in cells by FoxO protein degradation, transcription or mutation in FoxO genes. 35 Our previous studies demonstrated that aged Casp2 −/− mice have reduced FoxO1 and FoxO3. 11 The reduced FoxO protein level in Casp2 −/− is likely to contribute to the reduced antioxidant stress response seen in caspase-2-deficient mice following PQ treatment.
Autophagy is a process that is strongly linked to ageing and oxidative stress. 36 PQ also induces autophagy. 37 However, there were no differences in p62/SQSTM1 expression indicating similar rate of autophagy between WT and Casp2 −/− mice (Figure 4c ). Moreover, although no change in phospho p38 and phospho ERK was observed, active JNK (phospho JNK) levels were higher in Casp2 −/− mice injected with PQ, further suggesting increased −/− mice (n = 5,5 PBS injected; n = 7,10 PQ injected and n = 6,7 PQ+ NAC injected). (b) IL-1β were higher in aged Casp2 −/− mice after PQ exposure (n = 5,5 PBS injected; n = 7,7 PQ injected and n = 7,7 PQ+ NAC injected). (c) MIP2 levels were unaffected (n = 5,5 PBS injected; n = 7,7 PQ injected and n = 7,7 PQ+ NAC injected). IL-6 was measured in mice serum using mouse IL-6 ELISA kit (ebioscience Inc, San Diego, CA, USA), TNFα, IL-1β and MIP2 were measured using commercially available kits (R&D, systems, Minneapolis, MN, USA). (d) Protein oxidation was significantly higher in Casp2 −/− mice injected with PQ (n = 4,4 PBS injected; n = 8,7 PQ injected and n = 8,7 PQ+ NAC injected). (e) Lipid peroxidation increased after PQ treatment in both WT and Casp2 −/− mice but no difference between the two genotypes was observed (n = 3,4 PBS injected; n = 7,6 PQ injected and n = 6,6 PQ+ NAC injected). Activity of the key antioxidant enzymes, (f) SOD (n = 5,4 PBS injected; n = 8,7 PQ injected and n = 8,7 PQ+ NAC injected) and (g) Glutathione peroxidase (GSH-Px), remained unchanged in Casp2 −/− mice after low dose of PQ administration (n = 5,4 PBS injected; n = 8,7 PQ injected and n = 8,7 PQ+ NAC injected). Protein oxidation and lipid peroxidation were mearsured using protein carbonyl and TBARS assay kit (Cayman Chemical, Ann Arbor, MI, USA). SOD activity and GSH-Px were measured in lung lysates using kits from Cayman Chemical. The Graph Pad Prism software, version 6 (Graph Pad Inc.) was used for all statistical analyses. Data were analysed using unpaired Student's t-test. Data are presented as mean ± s.e.m. *P o0.05, **Po 0.01 and ***P o0.001 denote significant differences. n = WT, Casp2 −/− mice respectively.
Caspase-2 in oxidative stress S Shalini et al Homogenates were further treated by three freeze/thawed cycles in liquid nitrogen, clarified by centrifugation at 16 000 g and protein concentration determined by the BCA quantification (Pierce Biotechnology, Rockford, IL, USA). Lysates (100 μg) were resolved on 12% SDS-PAGE and transferred on polyvinylidene difluoride membrane and probed for the specified antibody for 2 h at room temperature or overnight at 4°C. Secondary antibodies, conjugated with alkaline phosphatase (AP, Merck, Millipore, Billerica, MA, USA) or Cy5 (GE Healthcare Life Sciences, Little Chalfont, UK), were incubated at room temperature for 1 h. Proteins were visualized using ECF (GE Healthcare Life Sciences). Western blot shows (a) caspase-2 cleavage after PQ exposure (FL Casp2: caspase-2 precursor; C Casp2: cleaved caspase-2, whereas (b) no Caspase 3 cleavage was detected (FL Casp3: full length caspase-3; ns: nonspecific). (c) Reduced Nrf2 expression in old Casp2 −/− mice, whereas no change in p53 and autophagy (p62/ SQSTM1) was observed. (d) PQ induced FoxO1 and SOD2 expression in the old WT mice lung lysates. No difference in SOD1 expression was observed. (e) Increased phosphor-JNK levels in PQ-treated old Casp2 −/− mice were observed, whereas no difference in ERK and p38 activation was detected. Data are representative of two separate blots. The following primary antibodies were used: SOD2 (sc30080) and Nrf2 (C20; sc722; Santa Cruz Biotechnology, Santa Cruz, CA, USA); p44/42 MAPK (Erk1/2; 137F5), phospho-p44/42 MAPK (Erk1/2; Thr202/Tyr204; D13.14.4E), JNK (2C6), Phospho-SAPK/JNK (Thr 183/Tyr185; 81E11), Phospho-p38 (Thr180/Tyr182), p38 MAPK, FoxO1 (C29H4) caspase 3 (8G10) and phospho-p53 (Ser 15; Cell Signalling Technology, Danvers, MA, USA), caspase-2 (clone 11B4), SOD1 (ab 13498; Abcam, Cambridge, UK); SQSTM1/p62 (2C11; Abnova, Taipei City, Taiwan); β-actin (Sigma-Aldrich, St Louis, MO, USA).
Caspase-2 in oxidative stress S Shalini et al stress experienced by Casp2 −/− mice. NAC pretreatment did not completely prevent this activation (Figure 4e and Supplementary Figure S6 ). JNK is a stress-induced protein kinase and its activation is frequently linked to increased stress. 38 Several groups have also implicated stress-induced JNK activation to autophagy induction. 39, 40 Loss of caspase-2 has been shown to induce autophagy. 41, 42 However, there were no detectable differences in autophagy in PQ-treated mice. Others have reported that caspase-2 activation is an upstream event that causes JNK activation during oxidative stress 43 or during doxorubicin-induced apoptosis. 44 However, activation of JNK does not entirely depend on caspase-2 and increased ROS/oxidative stress is a major trigger for JNK activation. 45 Dissociation of ASK1 (Apoptosis signalregulating kinase 1) from thioredoxin by ROS can activate JNK and p38. 45 Our study shows an important role for caspase-2 in preventing oxidative stress which would normally prevent JNK activation. The low dose of PQ used in the present study did not evoke any JNK activation in WT mice. On the contrary, by switching on pro-survival Nrf2 and FoxO, oxidative damage was minimized in WT mice. JNK activation is also linked to increased IL-6 secretion and inflammation. 46 It is likely that increased inflammation observed in Casp2 −/− mice is a consequence of JNK activity. In support of our observations, it has been observed that homocysteine-induced neurotoxicity involves downregulation of Nrf2, increased oxidative stress and JNK activation. 47 However, in the absence of any well-known caspase-2 substrates in stress response pathway, a clear mechanism remains elusive.
In order to assess cell death in response to PQ treatment, terminal deoxynucleotide transferase dUTP nick end labeling (TUNEL) was performed on lung tissue of old mice. However, we observed a negligible frequency of TUNEL-positive cells in PQtreated lungs, with no obvious differences between genotypes (Supplementary Figure S5) . The lack of cell death is likely because of the low PQ dose used in the study and also importantly depends on the duration of PQ exposure. Initial exposure to PQ causes an acute response resulting in alveolar cell death that occurs during the initial destructive phase (within hours and persisting up to 2-3 days). 16 In our experimental setting, mice were analysed 2 weeks after a single dose of PQ, a time when the secondary phase of PQ toxicity (known as the proliferative phase) occurs. 16 This is characterized by inflammatory cell infiltration, hyperplasia and fibrosis, which are clearly evident under our conditions (Figure 2a, Supplementary Figure S3 ).
In conclusion, our study has demonstrated that caspase-2 is activated in response to PQ-induced oxidative stress. The lowdose PQ challenge causes upregulation of FoxO, SOD2 and Nrf2 to detoxify ROS and limit oxidative damage in WT mice. Casp2 −/− mice are either unable to sense the increased ROS or are illequipped to manage ROS such as having a less active antioxidant defense mechanism that results in their having reduced ability to tolerate oxidative stress, resulting in increased oxidative damage. Identification of caspase-2 substrates involved in ROS generation and quenching can provide better insight into the mechanisms that regulate oxidative stress. ABBREVIATIONS GSH-Px, glutathione peroxidase; NAC, N-acetyl cysteine; PQ, paraquat; ROS, reactive oxygen species; SOD, superoxide dismutase.
